多环化合物及其用途

By modifying PDE3A activity or PDE3A/SLFN12 interaction, compounds and compositions have addressed the issues of drug resistance and low efficacy of existing antitumor drugs, enhancing the effectiveness of anticancer treatment and improving survival rates.

CN117062819BActive Publication Date: 2026-07-17NAT INST OF BIOLOGICAL SCI BEIJING +1
View PDF 11 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
NAT INST OF BIOLOGICAL SCI BEIJING
Filing Date
2022-03-23
Publication Date
2026-07-17

Smart Images

  • Figure QLYQS_1
    Figure QLYQS_1
  • Figure QLYQS_2
    Figure QLYQS_2
  • Figure QLYQS_3
    Figure QLYQS_3
Patent Text Reader

Abstract

提供了用于调节PDE3A活性或调节PDE3A / SLFN12的相互作用的多环化合物、组合物、和方法。本发明的化合物调节PDE3A活性或调节PDE3A / SLFN12的相互作用，且可用作抗肿瘤剂。
Need to check novelty before this filing date? Find Prior Art